| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.2M | -11.1% | -15.0% |
| Cost of Revenue | $3.4M | -10.5% | -13.6% |
| Gross Profit | $788K | -13.8% | -20.7% |
| R&D Expense | $49K | -42.7% | +1997.1% |
| SG&A Expense | $2.7M | -4.2% | -45.1% |
| Operating Income | -$2.5M | -28.6% | +63.2% |
| Pre-tax Income | -$2.5M | -24.3% | +63.3% |
| Income Tax | $46K | -15.8% | -25.8% |
| Net Income | -$2.5M | -21.0% | +63.6% |
| EPS (Basic) | $0.00 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.5M | -9.2% | -41.1% |
| Current Assets | $10.2M | -8.5% | -17.0% |
| Total Assets | $25.6M | -3.9% | -30.3% |
| Current Liabilities | $12.5M | +4.8% | +5.9% |
| Long-term Debt | $0 | — | — |
| Total Liabilities | $125.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.7M | — | — |
| Capital Expenditures | $3K | — | — |
| Investing Cash Flow | -$243K | — | — |
| Financing Cash Flow | $4.6M | — | — |
| Free Cash Flow | -$4.7M | — | — |
| +1.0% |
| -0.3% |
| Stockholders' Equity | -$99.2M | -2.3% | -14.1% |